Marijke Devos, MD
Hand Surgery · Silverdale, WANPI 1356874952
Payments from drug & device makers
What this record shows
This record is dominated by grants: $10,000 of the $15,240 with a category attached, or 65.6%. Arthrex accounts for 65.6% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $13,543 and has fallen 99.5% since, to $69 in 2024.
Across 40 payments — averaging $380.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$10K
- Medinc Of Texas$3K
- Stryker$1K
- Axogen$466
- Acumed LLC$426
- Trimed, Inc.$172
- plus $406 from 3 others
What the payments were for
- Grants$10,00066%
- Food & beverage$2,84019%
- Education$2,40016%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 1 | $10,000 |
| Medinc Of Texas | 5 | $2,599 |
| Stryker | 23 | $1,170 |
| Axogen | 2 | $466 |
| Acumed LLC | 3 | $426 |
| Trimed, Inc. | 1 | $172 |
| Endo Pharmaceuticals Inc. | 2 | $160 |
| Integra Lifesciences Corporation | 2 | $128 |
| Smith+Nephew | 1 | $118 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACUMED$493
- AVANCE NERVE GRAFT$466
- AxoGuard Nerve Connector$466
- AxoGuard Nerve Protector$466
- GAMMA$290
- AXSOS$173
- SALVATION$171
- T2$156
- XIAFLEX$146
- EVOS$118
How this compares
$15,240 in reported general payments places this provider in the 85th percentile of 75 hand surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 19 | $41 |
| Tramadol Hcl | 14 | $32 |
Paid to pharmacies, not to this prescriber.
Other hand surgery in Silverdale
- Margaret JainSilverdale$296
- Thomas TrumbleBellevue$824K
- Jerry HuangSeattle$428K
- Mary ThayerBellevue$51K
- Chelsea BoeSeattle$32K
- Anthony LauderLongview$19K
- Julie RobertsFederal Way$19K
- Gregory ByrdOlympia$17K
- Chad TurnerSpokane Valley$17K
- Benjamin JacobsVancouver$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.